Organization

Università Vita-Salute San Raffaele

6 clinical trials

3 abstracts

Abstract

Results of MOLTO, a multicenter, open label, phase II clinical trial evaluating venetoclax, atezolizumab and obinutuzumab combination in Richter syndrome.

Org: Niguarda Cancer Center, Laboratory of Experimental Hematology, Clinic of Hematology, Ente Ospedaliero Cantonale, Universita’ della Svizzera italiana,

Abstract

Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with HER2+ metastatic breast cancer (mBC): Updated survival results of DESTINY-Breast03.

Org: Sarah Cannon Research Institute/Tennessee Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Center, Seoul National University Hospital, Cancer Research Institute, Aichi Cancer Center Hospital,

Abstract

Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

Org: University Hospital of Schleswig Holstein, Klinikum Esslingen, University Hospital Rostock, Karolinska Institutet, Capio St. Göran’s Hospital,

Clinical trial

Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery: a Multi-centre Randomized Blinded Placebo Controlled Clinical Trial.

Status: Active (not recruiting), Estimated PCD: 2024-01-17

Clinical trial

Looking for a Blood Epigenetic Signature to Predict Female Infertility

Status: Recruiting, Estimated PCD: 2026-10-16

Clinical trial

Proton Pump Inhibitors (PPI) as a New Strategy for Therapy in Sepsis: Clinical Trial to Reduce Severity of Organ Failure and in Vitro Experiments to Search Specific Hallmarks in Monocytes From Septic Patients and to Characterize the Mechanism of Action of PPI

Status: Completed, Estimated PCD: 2023-08-21